Spots Global Cancer Trial Database for hormonal therapy
Every month we try and update this database with for hormonal therapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Light Emitting Diode for theTreatment of Genitourinary Syndrome of Menopause Associated With Breast Cancer Treatment | NCT03833726 | Atrophy;Vaginal Breast Cancer | Experimental: L... Sham Comparator... | 18 Years - 65 Years | Centro de Atenção ao Assoalho Pélvico | |
| Liver Safety Under Upfront Arimidex vs Tamoxifen | NCT00537771 | Breast Cancer | Anastrozole Tamoxifen | - | AstraZeneca | |
| PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer | NCT03621904 | Endometrial Can... Endometrial Can... Endometrial Can... | Hormonal Antine... | 18 Years - 110 Years | Radboud University Medical Center | |
| Exemestane and Cyclophosphamide for Metastatic Breast Cancer | NCT01963481 | Metastatic Beas... | Exemestane Cyclophosphamid... | 18 Years - | NYU Langone Health | |
| A Study of Bevacizumab Added to Trastuzumab Plus Docetaxel in the Neoadjuvant Setting in Participants With Early Stage HER2-Positive Breast Cancer | NCT01142778 | Breast Cancer | Bevacizumab Docetaxel Trastuzumab Surgery Radiotherapy Hormonal Therap... | 18 Years - | Hoffmann-La Roche | |
| PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer | NCT03621904 | Endometrial Can... Endometrial Can... Endometrial Can... | Hormonal Antine... | 18 Years - 110 Years | Radboud University Medical Center | |
| Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer | NCT00521781 | Prostatic Neopl... | Abraxane Leuprolide Bicalutamide | 18 Years - | The Methodist Hospital Research Institute | |
| Feasibility Study for the Determination of Oxysterols in Patients With Breast Cancer Receiving Hormonal Therapy With Tamoxifen or Not | NCT01553903 | Breast Cancer | Tamoxifen, Exemestane Anastrozole Letrozole | 18 Years - | Institut Claudius Regaud | |
| Assessing DNA Changes in High Risk Prostate Cancer to Determine Prognosis | NCT01350180 | Prostate Cancer | - | Sir Mortimer B. Davis - Jewish General Hospital | ||
| Exemestane and Cyclophosphamide for Metastatic Breast Cancer | NCT01963481 | Metastatic Beas... | Exemestane Cyclophosphamid... | 18 Years - | NYU Langone Health | |
| FESPET Study: Female EStrogen recePtor in Endometrial Cancer Treatment | NCT03489473 | Endometrial Can... | 18F-FES PET CT ... | 40 Years - | Radboud University Medical Center | |
| Multimedia-based Hormonal Therapy Information Program for Patients With Prostate Cancer | NCT04693910 | Prostatic Neopl... | Multimedia-Base... | 20 Years - | National Taipei University of Nursing and Health Sciences | |
| Clinical Trial Comparing 3-D RT vs. IMRT in Post- Prostatectomy Prostate Cancer Patients | NCT02678520 | Prostate Cancer | 3-D Conformal R... Intensity Modul... Casodex, Zolade... | 18 Years - | University of Kansas Medical Center | |
| Step by Step After Cancer | NCT02785861 | Breast Cancer | supervision of ... distance superv... | 18 Years - 75 Years | Centre Hospitalier Universitaire, Amiens | |
| Efficacy and Safety of Clino-san on Vaginal Dryness of Breast Cancer Patients | NCT00607295 | Breast Cancer Vaginal Atrophy | clino-san vagin... | 20 Years - | Seoul National University Hospital | |
| Clinical Trial Comparing 3-D RT vs. IMRT in Post- Prostatectomy Prostate Cancer Patients | NCT02678520 | Prostate Cancer | 3-D Conformal R... Intensity Modul... Casodex, Zolade... | 18 Years - | University of Kansas Medical Center | |
| Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy | NCT00661531 | Breast Cancer Cancer of the B... Neoplasms, Brea... | Estrace Anastrozole | 18 Years - | Georgetown University | |
| Small-group, Virtual Program for Improving Symptoms and Distress Related to Hormonal Therapy for Breast Cancer Survivors | NCT03837496 | Breast Cancer Adherence, Medi... | STRIDE Medication Moni... | 21 Months - | Massachusetts General Hospital | |
| Chemotherapy Effect on Brain Structure, Neurophysiology and Psychomotor Behavior in Breast Cancer Patients | NCT02896504 | Breast Cancer | Exposure: Adjuv... Exposure: Adjuv... | 20 Years - 70 Years | Kessler Foundation | |
| Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer. | NCT00034125 | Breast Neoplasm... | LY353381 tamoxifen | 18 Years - | Eli Lilly and Company | |
| Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca. | NCT00240071 | Metastatic Brea... | Avastin Hormonal therap... | 19 Years - 80 Years | University of Alabama at Birmingham | |
| Hypofractionated, Dose Escalation Radiotherapy for High Risk Adenocarcinoma of the Prostate | NCT01444820 | Prostate Cancer | hypofractionati... conventional | 18 Years - | Sir Mortimer B. Davis - Jewish General Hospital | |
| Paclitaxel and Radiation Therapy in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer | NCT00647218 | Breast Cancer | Post-operative ... neoadjuvant the... therapeutic sur... Radiation thera... Hormonal Therap... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Combining CRLX101, a Nanoparticle Camptothecin, With Enzalutamide in People With Progressive Metastatic Castration Resistant Prostate Cancer Following Prior Enzalutamide Treatment | NCT03531827 | Metastatic Cast... Prostate Neopla... | enzalutamide CRLX101 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer | NCT03621904 | Endometrial Can... Endometrial Can... Endometrial Can... | Hormonal Antine... | 18 Years - 110 Years | Radboud University Medical Center | |
| Step by Step After Cancer | NCT02785861 | Breast Cancer | supervision of ... distance superv... | 18 Years - 75 Years | Centre Hospitalier Universitaire, Amiens | |
| Effect of Kinesiotaping for the Treatment of Hormone-induced Myalgia in Women Given Breast Cancer Survivors | NCT02406794 | Breast Neoplasm... | Neuromuscular t... | 18 Years - | University of Malaga | |
| Study of the Effects of Chemotherapy on Memory and Other Mental Functions in Women With Breast Cancer | NCT00260975 | Breast Cancer | 50 Years - 65 Years | Ottawa Hospital Research Institute | ||
| Genomic Guided Therapy With Dasatinib or Nilutamide in Metastatic Castration-Resistant Prostate Cancer | NCT00918385 | Prostate Cancer | Nilutamide Dasatinib | 18 Years - | Duke University | |
| Clinical Study on Auricular Points Sticking Plus Chinese Medication for Hot Flashes in Breast Cancer Women | NCT03540251 | Breast Cancer Hormonal Therap... Hot Flashes Acupuncture | Auricular Point... | 30 Years - 55 Years | Longhua Hospital | |
| Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy | NCT00050011 | Breast Neoplasm... Osteoporosis | Zoledronic Acid Letrozole | 18 Years - 85 Years | Novartis | |
| Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer | NCT00521781 | Prostatic Neopl... | Abraxane Leuprolide Bicalutamide | 18 Years - | The Methodist Hospital Research Institute | |
| Mild Cognitive Impairment in Breast Cancer Patients | NCT01949376 | Breast Cancer Cognitive Impai... | 40 Years - 70 Years | Northwestern University | ||
| Chemotherapy Effect on Brain Structure, Neurophysiology and Psychomotor Behavior in Breast Cancer Patients | NCT02896504 | Breast Cancer | Exposure: Adjuv... Exposure: Adjuv... | 20 Years - 70 Years | Kessler Foundation | |
| Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer. | NCT00034125 | Breast Neoplasm... | LY353381 tamoxifen | 18 Years - | Eli Lilly and Company | |
| Effects of Diet and Osteopathy on Quality of Life and Inflammation in Breast Cancer Patients Under Hormonal Therapy | NCT06164119 | Breast Cancer | manual treatmen... manual treatmen... nutritional tre... | 18 Years - 85 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Exemestane and Cyclophosphamide for Metastatic Breast Cancer | NCT01963481 | Metastatic Beas... | Exemestane Cyclophosphamid... | 18 Years - | NYU Langone Health | |
| Efficacy and Safety of Clino-san on Vaginal Dryness of Breast Cancer Patients | NCT00607295 | Breast Cancer Vaginal Atrophy | clino-san vagin... | 20 Years - | Seoul National University Hospital | |
| Study of Body Composition in Patients Treated by Adjuvant Hormonal Therapy for Breast Cancer (MetaCa2) | NCT02509871 | Hormonal Therap... Breast Cancer | Body compositio... | 18 Years - | Centre Jean Perrin | |
| Feasibility Study for the Determination of Oxysterols in Patients With Breast Cancer Receiving Hormonal Therapy With Tamoxifen or Not | NCT01553903 | Breast Cancer | Tamoxifen, Exemestane Anastrozole Letrozole | 18 Years - | Institut Claudius Regaud | |
| Assessing DNA Changes in High Risk Prostate Cancer to Determine Prognosis | NCT01350180 | Prostate Cancer | - | Sir Mortimer B. Davis - Jewish General Hospital | ||
| Abiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and Enzalutamide | NCT01946165 | Prostate Cancer | Abiraterone Ace... Prednisone Enzalutamide LHRHa | 18 Years - | M.D. Anderson Cancer Center | |
| Assessing DNA Changes in High Risk Prostate Cancer to Determine Prognosis | NCT01350180 | Prostate Cancer | - | Sir Mortimer B. Davis - Jewish General Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
